3 More Neil Woodford Core Picks For Your ISA: GlaxoSmithKline plc, Legal & General Group Plc & Imperial Brands PLC

Woodford core holdings GlaxoSmithKline plc (LON:GSK), Legal & General Group Plc (LON:LGEN) and Imperial Brands PLC (LON:IMB) could be great picks for your ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors have plenty to worry about at the moment what with the upcoming UK referendum on EU membership, volatile commodity markets and a growth slowdown in China.

However, top fund manager Neil Woodford continues to believe that his equity income fund’s core blue-chip companies can still deliver in an uncertain and low-growth world.

If you’re looking for shares for your ISA in these difficult times, GlaxoSmithKline (LSE: GSK), Legal & General (LSE: LGEN) and Imperial Brands (LSE: IMB) — three Woodford core holdings — have a lot going for them.

GlaxoSmithKline

A Woodford fund update almost a year ago said: “GlaxoSmithKline is a long-term holding and one which has been frustratingly disappointing for much of the holding period”.

Last month, Glaxo reported a further decline in earnings in its annual results, the share price remains depressed … and Woodford and his team maintain their faith, saying recently: We continue to see substantial long-term value, believing that the sum of Glaxo’s constituent parts is significantly greater than the whole, as reflected by the current share price”.

Indeed, Woodford, and a number of other major shareholders, have for some time been calling for a radical, value-unlocking restructuring of Glaxo: a break-up, or partial break-up, of the four-business conglomerate.

An announcement last week that chief executive Sir Andrew Witty will retire in March next year could open the door for change. Not surprisingly, Woodford has expressed a “strong preference for an external candidate” to replace Witty.

Glaxo has decent prospects in its present form, with a return to growth expected this year, but there’s potential for shareholder returns to be significantly enhanced by the kind of restructuring Woodford and others are pressing for.

Legal & General

Insurer and asset manager Legal & General has seen its shares under pressure this year. The market has been concerned about the company’s corporate bond portfolio in an environment of deteriorating credit quality in the asset class, particularly in the troubled oil and mining sectors.

Woodford and his team are less concerned, saying early this month: We are reassured about its quality and diversity. We see [L&G’s] recent weakness as unjustified, given its strong cash generation, high yield and the fact that it looks well placed to deliver attractive rates of dividend growth.”

L&G has subsequently released results showing cash generation up 14% and a 19% dividend increase, giving ample support to Woodford’s view.

Imperial Brands

Imperial Brands has recently changed its name from Imperial Tobacco, but the business hasn’t changed and neither has Woodford’s positive view on the industry and the company.

Stephen Lamacraft, the Woodford team’s mature blue-chip specialist, recently reiterated that: “Tobacco has, over the years, proven itself to be an extremely dependable industry — delivering steady and sustainable growth in cash flows, earnings and dividends year in, year out, regardless of the economic environment”.

As far as Imperial Tobacco, in particular, is concerned, he added that last month’s trading update demonstrates “the stock’s attractive and dependable growth characteristics”.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£20,000 in savings? Here’s how I’d aim to turn that into passive income of £903 a month

Our writer shares one approach to passive income investing, spotlighting a quality FTSE 100 stock he recently added to his…

Read more »

Investing Articles

Great dividend stocks! Here’s the forecast for Associated British Food shares to 2027

Associated British Foods' shares have dropped in value this year. Does this present a dip-buying opportunity for dividend investors to…

Read more »

Investing Articles

Should I sell my FTSE All-Share index fund and buy a S&P 500 tracker instead?

Harvey Jones is wondering whether now is a good time to invest more money in the S&P 500, after a…

Read more »

Investing Articles

Should I buy dirt-cheap BT shares after the recent pullback?

BT shares were on the up but now they're sliding again after the board trimmed full-year guidance. Now Harvey Jones…

Read more »

Investing Articles

Up 28%, can the easyJet share price keep rising?

The easyJet share price has gained altitude over one year but plunged over five. Is now an attractive time for…

Read more »

British Isles on nautical map
Investing Articles

Should I buy more BAE Systems shares at 1,350p?

BAE Systems shares have had a fantastic run since early 2022, yet still don't appear overvalued. Is it now time…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

7% yield and a cheap valuation! Is this one of the best shares to buy this month?

Christopher Ruane has been looking for cheap shares to buy. This one has a 7% dividend yield, so is it…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Should I buy National Grid shares for the big dividend before it’s too late?

This year's price weakness has left National Grid shares on what looks like a tempting valuation. I hope it doesn't…

Read more »